LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases

This publication has 120 references indexed in Scilit:

• LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin
  Cancer Cell, 2013
• AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
  Cell Metabolism, 2013
• AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
  Cell Metabolism, 2011
• Glutamine addiction: a new therapeutic target in cancer
  Trends in Biochemical Sciences, 2010
• AMP-activated protein kinase and its downstream transcriptional pathways
  Cellular and Molecular Life Sciences, 2010
• A role for AMPK in the inhibition of glucose-6-phosphate dehydrogenase by polyunsaturated fatty acids
  Biochemical and Biophysical Research Communications, 2009
• Oncogenic B-RAF Negatively Regulates the Tumor Suppressor LKB1 to Promote Melanoma Cell Proliferation
  Molecular Cell, 2009
• LKB1 modulates lung cancer differentiation and metastasis
  Nature, 2007
• Protein Sensors for Membrane Sterols
  Cell, 2006
• The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism
  Nature, 2005